Profile of deferasirox for the treatment of patients with non-transfusion-dependent thalassemia syndromes

It has been clearly shown that iron overload adds progressively significant morbidity and mortality in patients with non-transfusion-dependent thalassemia (NTDT). The lack of physiological mechanisms to eliminate the excess of iron requires effective iron chelation therapy. The reduced compliance to...

Descripción completa

Detalles Bibliográficos
Autores principales: Ricchi, Paolo, Marsella, Maria
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2015
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687615/
https://www.ncbi.nlm.nih.gov/pubmed/26719673
http://dx.doi.org/10.2147/DDDT.S40694

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687615/
https://www.ncbi.nlm.nih.gov/pubmed/26719673
http://dx.doi.org/10.2147/DDDT.S40694

Ejemplares similares